Rapid Dose Therapeutics Corp.
DOSE
Rank in Stocks
#28975
Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life... Rapid Dose Therapeutics Corp., headquartered in Burlington, Canada, is a life sciences enterprise dedicated to developing advanced drug delivery technologies aimed at improving health results and individuals' quality of life. The company's flagship product is QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter medicines—directly into the bloodstream. They offer specific QuickStrip variants like QuickStrip energy for caffeine delivery, QuickStrip B12 for vitamin B12 supplementation, and QuickStrip sleep for melatonin. Beyond its proprietary products, the firm also delivers comprehensive services encompassing product innovation, manufacturing, and consultation to industries including nutraceuticals, cannabis healthcare, and pharmaceutical production. Rapid Dose Therapeutics maintains a significant research collaboration with McMaster University, focusing on crafting enhanced biopolymer compositions for oral dissolvable thin films and investigating an orally administered vaccine candidate for COVID-19.
Share Price
$0.06727378
Last synced: 2026-11-09
Market Cap
$9.27M
Change (1 day)
-9.52%
Change (1 year)
-30.14%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Rapid Dose Therapeutics Corp. (DOSE)
Category
Healthcare
Operating Margin for Rapid Dose Therapeutics Corp. (DOSE)
Operating Margin as of November 2026 TTM: -73.59%
According to Rapid Dose Therapeutics Corp.'s latest financial reports, its current operating margin (TTM) is -73.59%. At the end of 2025 the company had an operating margin of 259.18%.
Operating Margin history for Rapid Dose Therapeutics Corp. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -73.59% | -128.39% |
| 2025 | 259.18% | -170.70% |
| 2024 | -366.57% | -30.85% |
| 2023 | -530.14% | 109.43% |
| 2022 | -253.14% | 7.58% |
| 2021 | -235.30% | -96.82% |
| 2020 | -7,394.23% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.52% |
US
|
|
| -149.01% | -97.98% |
US
|
|
| 25.57% | -100.35% |
AU
|
|
| 31.23% | -100.42% |
BE
|
|
| 29.35% | -100.40% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Rapid Dose Therapeutics Corp.'s operating margin
What is Rapid Dose Therapeutics Corp.'s operating margin?
Rapid Dose Therapeutics Corp.'s operating margin is -73.59%, as of Nov 2026.
What was Rapid Dose Therapeutics Corp.'s operating margin in 2025?
In 2025, Rapid Dose Therapeutics Corp.'s operating margin was 259.18%, compared with -366.57% in 2024.
How has Rapid Dose Therapeutics Corp.'s operating margin changed since 2020?
From 2020 to 2025, Rapid Dose Therapeutics Corp.'s operating margin was highest in 2025 (259.18%) and lowest in 2020 (-7,394.23%).
How does Rapid Dose Therapeutics Corp.'s operating margin compare with similar companies?
Rapid Dose Therapeutics Corp.'s operating margin (-73.59%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.